相关实验视频

Updated: Jun 17, 2025

The Use of Reverse Phase Protein Arrays RPPA to Explore Protein Expression Variation within Individual Renal Cell Cancers

The Use of Reverse Phase Protein Arrays RPPA to Explore Protein Expression Variation within Individual Renal Cell Cancers

Published on: January 22, 2013

在清细胞细胞癌中解码PTEN调节:生物标志物发现和治疗见解的途径

Ângela Alves¹, Rui Medeiros², Ana Luísa Teixeira³

¹Molecular Oncology and Viral Pathology Group, Research Center of IPO-Porto (CI-IPOP) &RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO-Porto), Porto Comprehensive Cancer Center (Porto.CCC), 4200-072 Porto, Portugal; School of Medicine and Biomedical Sciences (ICBAS), University of Porto, 4050-513 Porto, Portugal.

Biochimica et biophysica acta. Reviews on cancer

|August 8, 2024

概括

了解清细胞细胞癌 (ccRCC) 中的PTEN损失是关键. 这篇评论探讨了PTEN抑制的机制,提供了对这种致命癌的潜在生物标志物和治疗方法的见解.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
癌症研究癌症研究

背景情况:

细胞癌 (RCC) 是成年人中最常见的脏固体瘤,也是最致命的泌尿癌.
清细胞细胞癌 (ccRCC) 是主要的亚型,其特点是具有侵略性的表型和治疗耐药性.
PI3K/AKT信号通路在ccRCC瘤发生过程中具有关键作用,异常激活导致预后不佳.

研究的目的:

审查ccRCC中PTEN抑制的基础分子机制.
突出了解PTEN在ccRCC中的作用的预后,预测和治疗潜力.
确定潜在的生物标志物和治疗目标,以改善ccRCC管理.

主要方法:

在ccRCC中对PTEN无活化的分子机制的文献综述.
分析PTEN作为PI3K/AKT信号轴的对手的作用.
综合有关PTEN对ccRCC进展和患者结局影响的信息.

主要成果:

在ccRCC中经常观察到PTEN损失或失活,这有助于瘤的攻击性行为.
通过对抗PI3K/AKT通路,PTEN起到关键的瘤抑制作用.
了解PTEN机制可以揭示ccRCC的漏洞.

结论:

抑制PTEN是ccRCC进展和治疗耐药性的重要驱动因素.
针对PTEN通路或了解其失活机制可能会提供新的治疗策略.
对PTEN作用的进一步研究对于改善ccRCC患者监测和治疗结果至关重要.

关键词:

生物标志物生物标志物清细胞脏细胞癌.在这里,我们可以使用PTEN.治疗目标治疗目标

更多相关视频

Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients

Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients

Published on: November 19, 2019

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Published on: February 7, 2021

相关概念视频

mTOR Signaling and Cancer Progression

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...

Cancer-Critical Genes II: Tumor Suppressor Genes

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

Abnormal Proliferation

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...